44 In addition, anergic cells Usually keep the next susceptibility to apoptosis Until anti-apoptotic proteins such as BCL2 are overexpressed, as is the case for CLL cells.forty five In fact, most major therapeutic advancements happening in the final 10 years are connected to the inhibition of BCR and BCL2-mediated signaling.Every other data you fin